Intelligent Bio Solutions Expands Clinical Validation of Fingerprint Drug Screening Technology
NEW YORK, June 16, 2026 Intelligent Bio Solutions (INBS) announced the initiation of a critical clinical Interference Study designed...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
NEW YORK, June 16, 2026 Intelligent Bio Solutions (INBS) announced the initiation of a critical clinical Interference Study designed...
NEW YORK, April 2, 2026 Intelligent Bio Solutions Inc. has achieved a critical milestone in its regulatory journey by...
